Showing posts with label Global Digital Pathology Market. Show all posts
Showing posts with label Global Digital Pathology Market. Show all posts

Sunday, September 18, 2022

Global Digital Pathology Market Growth Is Propelled By The Rising Prevalence Of Cancer: Ken Research

 Buy Now

Market Overview

Digital pathology is a setting for image-based information that is made possible by computer technology and enables the management of data produced by a digital slide. Tests that were formerly carried out by pathologists using five instruments can now be done with a single computerized device. These technologies, which also involve high-resolution sample scanning, online slide storage, image processing, and analysis on a computer, enable pathologists to cross-examine slides without physical evidence. Making primary pathological diagnoses from digital images immediately, remote pathology, archiving, and image analysis are examples of clinical uses. Applications outside of medicine include education, research, and skill evaluation. The rising incidence of cancer and the fast-expanding senior population are the factors that are contributing to the growing acceptance of digital pathology.


Report Analysis

According to the research report, “Digital Pathology Market: Current Analysis And Forecast (2021-2027) states that the Digital Pathology Market will grow rapidly during the forecasted period of 2027 due to the increasing prevalence of cancer and the rise in demand for accurate diagnostics. The market for digital pathology is also anticipated to rise as a result of growing applications of digital pathology in drug development and companion diagnostics, as well as rising usage of digital pathology to improve lab efficiency. Additionally, the development of a new digital pathology system by a large number of key players will boost the growth of the digital pathology market. Furthermore, the robust adoption of Artificial Intelligence based Digital Tools will foster the digital pathology industry’s progress.

Segmentation

  • By Product Type

On the basis of product type, the Digital Pathology Market is primarily split into Scanner, Software, and Storage systems. Among these, the scanner category held a substantial market share. The expansion of the category is attributed to rising R&D expenditures in the pharmaceutical and medical device sectors as well as the rapid uptake of digital pathology systems.

  • By Application

In terms of applications, the Digital Pathology Market includes Teleconsultation, Training, Disease Diagnosis, and Drug Discovery. Because of the growth in the occurrence of rare diseases and expanding R&D activities in the medication development process, the drug discovery category accounted for a considerable proportion of the market.

To Learn More About This Report Request A Free Sample Copy

  • By End-Users

The Digital Pathology Market in terms of end-users constitutes Pharmaceutical & Biotechnology Companies, Academic & Research, and Hospitals. A sizeable portion of the digital pathology industry was accounted for by the pharmaceutical and biotechnology industries. The increasing use of digital pathology for drug discovery research and drug toxicology testing is responsible for the rise of this market segment.

Key Players

Some major key players in the Digital Pathology Market are:

  • Nikon Corporation
  • Indica Labs Inc.
  • Glencoe Software Inc.
  • Hamamatsu Photonics K.K.
  • Perkinelmer Inc.
  • 3dhistech Ltd.
  • Danaher Corporation
  • Koninklijke Philips N.V.
  • Visiopharm A/S
  • Others

Geographical Analysis

Based on the geographical analysis, the Digital Pathology Market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North American market held the highest market share among these regions in 2020 and is anticipated to expand at a strong CAGR over the forecasted period. This can be due to encouraging government initiatives towards the development of technologically advanced systems, ongoing R&D investments, increasing usage of digital imaging, and the presence of large players promoting the industry growth in the area.

Future Projections

Over the impending years, the Digital Pathology Market will grow with a high CAGR because of the rising prevalence of cancer coupled with a rapidly growing geriatric population during the anticipated period of 2027. Additionally, a greater emphasis on enhancing workflow effectiveness and the need for quicker diagnostic tools for chronic diseases have been major market drivers.

For More Information on the Research Report, refer to below links: –

Global Digital Pathology Market

Related Report: -

Global Digital Pathology Market Research Report, by Type (Human Pathology, Animal Pathology), Product (Hardware, Software), Application (Disease Diagnosis, Mhealth, Drug Discovery) and End-Users (Hospitals, Diagnostic Centers) - Global Forecast Till 2023

Contact Us: -

Ken Research

Ankur Gupta, Head Marketing & Communications

support@kenresearch.com

+91-9015378249

Friday, December 6, 2019

Rise in Prevalence of Chronic Diseases Estimated to Drive Global Digital Pathology Market over the Forecast Period: Ken Research

Digital pathology is a dynamic and image-based environment technology, which enables the management, acquisition, and interpretation of pathology information generated from a digitized glass slide. It converts glass slides into digital slides that can be observed, managed, shared or examined on a computer monitor. The key benefits are included better efficiency, quicker & increasingly effective work process, portability & durability, better results for patients, cutting costs etc.

According to study, “Global Digital Pathology Market Research Report, by Type (Human Pathology, Animal Pathology), Product (Hardware, Software), Application (Disease Diagnosis, Mhealth, Drug Discovery) and End-Users (Hospitals, Diagnostic Centers) - Global Forecast Till 2023” the key companies operating in the global digital pathology market are Koninklijke Philips N.V., Inspirata, Olympus Corporation of the Americas, 3DHISTECH Ltd., Huron Digital Pathology Inc., Definiens, F. Hoffmann-La Roche Ltd, Danaher Corporation (Leica Biosystems GmbH), Mikroscan Technologies, Inc., micro dimensions GmbH. The key players are focused on receiving regulatory approvals for new products to boost their market share, which in turn is anticipated to boost the market growth.

Based on type, digital pathology market is segmented into veterinary pathology and human pathology. Human pathology segment dominates the market owing to rise in number of collaborations between pathology laboratories, academic institutes & universities and increase in utilization of digital systems. Based on product type, market is segmented into scanner, software, communication systems, and storage systems. Software product segment is estimated to observe notable growth, as these products are user-friendly and feature analytical & advanced functions for diagnosis purposes. Based on technology, market is segmented into whole slide imaging, static telepathology, telepathology and dynamic telepathology. Based on application, market is segmented into disease diagnosis, drug discovery, teleconsultation, and training & education. The telecnsultation segment is expected to witness considerable growth due to growth in demand for quality healthcare and rise in diagnosis of diseases during the forecast period. In addition, based on application, market is segmented into pharmaceutical & biotechnology companies, academic institutes & research laboratories and hospitals & clinics.

The digital pathology market is driven by increase in spending on the healthcare & IT sector, followed by rise in prevalence of chronic diseases, surge in diagnosis in remote regions, rise in availability of funds for research, increase in geriatric population, ease of consultation and rise in applications of radiology information systems. However, lack of skilled radiology professionals, high cost of software and security concerns may impact the market. Moreover, increase in potential of digital pathology is a key opportunity for market. Furthermore, integration of artificial intelligence (AI) technologies is a major trend for market.

Based on geography, the North-American region dominates the digital pathology market owing to well-developed healthcare sector, presence of some of the matured market players and high per capita healthcare expenditures in the region. The Asian-Pacific region is estimated to witness higher growth rate due to huge patient population and favorable government policies over the forecast period. It is anticipated that future of the market will be bright because of rise in government support for research & development (R&D) activities during the forecast period. The global market is projected to reach a market value of US $8,305.6 million by 2023 from US $3,937 million in 2017 and is projected to register a CAGR of 13.04% throughout the forecast period from 2018 to 2023.

For more information, click on the link below:

Contact Us:    
Ken Research                                   
Ankur Gupta, Head Marketing & Communications
+91 9015378249